Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 106
  2. 107
  3. 108
  4. 109
  5. 110
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Secukinumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4033-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Ustekinumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4034-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Ustekinumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4034-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4035-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4035-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Sintilimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5001-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Sintilimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5001-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Toripalimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5002-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Toripalimab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5002-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Camrelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5003-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Camrelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5003-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Tislelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5004-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Tislelizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA Humanized ICH5004-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH5005-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH5005-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Naptumomab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5007-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Naptumomab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5007-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Aducanumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5008-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Aducanumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5008-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Gantenerumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5009-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Gantenerumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5009-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Nesvacumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5010-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Nesvacumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5010-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Belantamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5011-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Belantamab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5011-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Name Preis
Secukinumab Biosimilar -­ Research Grade Anmelden Secukinumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Ustekinumab Biosimilar -­ Research Grade Anmelden Ustekinumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Ustekinumab Biosimilar -­ Research Grade Anmelden Ustekinumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Vedolizumab Biosimilar -­ Research Grade Anmelden Vedolizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Vedolizumab Biosimilar -­ Research Grade Anmelden Vedolizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Sintilimab Biosimilar -­ Research Grade Anmelden Sintilimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Sintilimab Biosimilar -­ Research Grade Anmelden Sintilimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Toripalimab Biosimilar -­ Research Grade Anmelden Toripalimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Toripalimab Biosimilar -­ Research Grade Anmelden Toripalimab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Camrelizumab Biosimilar -­ Research Grade Anmelden Camrelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Camrelizumab Biosimilar -­ Research Grade Anmelden Camrelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Tislelizumab Biosimilar -­ Research Grade Anmelden Tislelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Tislelizumab Biosimilar -­ Research Grade Anmelden Tislelizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Durvalumab Biosimilar -­ Research Grade Anmelden Durvalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Durvalumab Biosimilar -­ Research Grade Anmelden Durvalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Naptumomab Biosimilar -­ Research Grade Anmelden Naptumomab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Naptumomab Biosimilar -­ Research Grade Anmelden Naptumomab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Aducanumab Biosimilar -­ Research Grade Anmelden Aducanumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Aducanumab Biosimilar -­ Research Grade Anmelden Aducanumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Gantenerumab Biosimilar -­ Research Grade Anmelden Gantenerumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Gantenerumab Biosimilar -­ Research Grade Anmelden Gantenerumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Nesvacumab Biosimilar -­ Research Grade Anmelden Nesvacumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Nesvacumab Biosimilar -­ Research Grade Anmelden Nesvacumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Belantamab Biosimilar -­ Research Grade Anmelden Belantamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Belantamab Biosimilar -­ Research Grade Anmelden Belantamab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 106
  2. 107
  3. 108
  4. 109
  5. 110
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top